You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

open-label phase II study

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MSI-H Colorectal Cancer, Tislelizumab, Oxaliplatin Trial (Tislelizumab)

Not yet recruiting
  • MSI-H Colorectal Cancer
  • +3 more
  • (no location specified)
Apr 23, 2023

Fanconi Anemia Trial in Madrid (Eltrombopag)

Completed
  • Fanconi Anemia
  • Madrid, Spain
    Hospital Infantil Universitario Niño Jesús (HIUNJ)
Sep 20, 2023

Prostatic Adenocarcinoma Trial in Seoul (Enzalutamide)

Not yet recruiting
  • Prostatic Adenocarcinoma
  • Seoul, Korea, Korea, Republic of
    Samsung Medical Center
Aug 23, 2023

Furmonertinib, EGFR-mutation, NSCLC Trial in Beijing (Furmonertinib)

Recruiting
  • Furmonertinib
  • +3 more
  • Beijing, China
    Ethics Committee
Jul 15, 2022

Metastatic Colorectal Cancer Trial (Cetuximab and irinotecan)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab and irinotecan
  • (no location specified)
Jul 26, 2023

Glioblastoma Multiforme Trial (WP1066)

Not yet recruiting
  • Glioblastoma Multiforme
  • (no location specified)
May 18, 2023

Homozygous Familial Hypercholesterolemia Trial (SHR-1918)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • (no location specified)
Aug 22, 2023

NSCLC, Breast Cancer, HNSCC Trial in Chang chun (YL202 should be intravenously infused)

Not yet recruiting
  • NSCLC
  • +3 more
  • YL202 should be intravenously infused
  • Chang chun, Jilin, China
    Jilin Provincial Cancer Hospital
Oct 25, 2023

Contraception Trial in Berlin (MR-130A-01 Transdermal patch)

Recruiting
  • Contraception
  • MR-130A-01 Transdermal patch
  • Berlin, Germany
    dinox GmbH
Sep 15, 2023

HNSCC Trial (Danvatirsen, Pembrolizumab)

Not yet recruiting
  • HNSCC
  • (no location specified)
Apr 3, 2023

Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • New Haven, Connecticut
    Yale Cancer Center
Oct 20, 2023

Primary Visceral Leishmaniasis Trial in Gondar (LXE408, sodium stibogluconate, Paromomycin)

Not yet recruiting
  • Primary Visceral Leishmaniasis
  • Gondar, Ethiopia
    University of Gondar
Jul 14, 2023

COVID-19 Infection Trial in Bellinzona (Enzalutamide)

Terminated
  • COVID-19 Infection
  • Bellinzona, Switzerland
    Oncology Institute of Southern Switzerland (IOSI)
Aug 7, 2022

Vulvar Cancer Trial in China (AK104)

Not yet recruiting
  • Vulvar Cancer
  • Fuzhou, Fujian, China
  • +5 more
Jun 27, 2023

Small-cell Lung Cancer Trial in Guangzhou (Serplulimab)

Recruiting
  • Small-cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong Provincial Perople's Hospital
Jul 20, 2023

Retinitis Pigmentosa Trial in Durham (ADX-2191)

Recruiting
  • Retinitis Pigmentosa
  • Durham, North Carolina
    Duke Eye Center
Sep 26, 2022

Blood Cancer, Refractory Immune Cytopenias Trial in United States (Isatuximab)

Not yet recruiting
  • Blood Cancer
  • Refractory Immune Cytopenias
  • Isatuximab
  • Basking Ridge, New Jersey
  • +6 more
May 15, 2023

Breast Cancer Trial in Yantai (pyrotinib combined with trastuzumab, dalpiciclib and letrozole)

Recruiting
  • Breast Cancer
  • pyrotinib combined with trastuzumab, dalpiciclib and letrozole
  • Yantai, Shandong, China
    Yantai Yuhuangding Hospital
Mar 23, 2023

Ovarian Squamous Cell Carcinoma Trial in Niigata (MK-3475 (pembrolizumab))

Not yet recruiting
  • Ovarian Squamous Cell Carcinoma
  • MK-3475 (pembrolizumab)
  • Niigata, Japan
    Niigata University Medical & Dental Hosptal
Feb 20, 2023

Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)

Not yet recruiting
  • Monoclonal Gammopathy of Uncertain Significance
  • Zanubrutinib Oral Product
  • Utrecht, Netherlands
    University Medical Center Utrecht
Jul 6, 2023

Resectable Pancreatic Cancer Trial in Tianjin (AG Followed by FOLFIRINOX)

Recruiting
  • Resectable Pancreatic Cancer
  • AG Followed by FOLFIRINOX
  • Tianjin, Tianjin, China
    Rui Liu
Jan 8, 2023

Gastric and Gastroesophageal Junction Adenocarcinoma Trial (Pembrolizumab (Keytruda®), Trifluridine/Tipiracil (Lonsurf®))

Not yet recruiting
  • Gastric and Gastroesophageal Junction Adenocarcinoma
  • Pembrolizumab (Keytruda®), Trifluridine/Tipiracil (Lonsurf®)
  • (no location specified)
Aug 17, 2022

Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)

Recruiting
  • Classical Hodgkin Lymphoma
  • Zimberelimab 240mg
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
Jun 15, 2023

Oligodendroglioma, Adult Trial in Philadelphia (Abemaciclib 200 MG)

Active, not recruiting
  • Oligodendroglioma, Adult
  • Abemaciclib 200 MG
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Sep 6, 2022

Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in United States (AZD4635, Oleclumab, Durvalumab)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Denver, Colorado
  • +8 more
Jan 12, 2023